The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?
- PMID: 35501718
- PMCID: PMC9058734
- DOI: 10.1186/s12883-022-02689-z
The diagnostic dilemma of idiopathic intracranial hypertension in a child with acute lymphoblastic leukemia: COVID-19 or cytosine arabinoside?
Abstract
Background: Idiopathic intracranial hypertension is a rare neurological condition among children. Its manifestations vary from mild headaches to loss of vision. Although rare, COVID-19 infection and high dose cytosine arabinoside have been reported as risk factors for this neurological disorder. In patients with acute leukemia, idiopathic intracranial hypertension diagnosis is simple, but finding its etiology can be difficult.
Case presentation: We report a case of a 9-year-old boy with an ongoing treatment for T-acute lymphoblastic leukemia presenting with persistent headaches and diplopia. A diagnosis of idiopathic intracranial hypertension was retained based on clinical, imaging and laboratory findings. Due to its rarity, we describe its clinical and therapeutic features and highlight the challenging etiological dilemma between COVID-19 infection and high dose cytosine arabinoside administration.
Conclusion: Persistent headache in a pediatric patient with leukemia can be due to many neurological disorders other than leukemic relapse. Given the improvement of the neurological symptoms after the SARS-CoV-2 PCR negativization and the successful re-introduction of high dose cytosine Arabinoside, the diagnosis of idiopathic intracranial hypertension associated with Covid-19 infection was withheld.
Keywords: Acute lymphoblastic leukemia; COVID-19; Case report; Headache; Idiopathic intracranial hypertension.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Idiopathic intracranial hypertension associated with SARS-CoV-2 infection in an adult male patient: a case report and review of the literature.J Med Case Rep. 2024 Apr 25;18(1):206. doi: 10.1186/s13256-024-04519-x. J Med Case Rep. 2024. PMID: 38658977 Free PMC article. Review.
-
Intracranial hypertension secondary to high dose cytosine arabinoside - A case study.J Infect Chemother. 2017 May;23(5):319-322. doi: 10.1016/j.jiac.2016.11.005. Epub 2016 Dec 20. J Infect Chemother. 2017. PMID: 28011351
-
Novel coronavirus infection (COVID-19) in a 12-year-old boy with acute lymphoblastic leukemia.J Cancer Res Ther. 2022 Dec;18(Supplement):S478-S480. doi: 10.4103/jcrt.JCRT_653_20. J Cancer Res Ther. 2022. PMID: 36511009
-
Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases.Semin Pediatr Neurol. 2021 Dec;40:100922. doi: 10.1016/j.spen.2021.100922. Epub 2021 Sep 4. Semin Pediatr Neurol. 2021. PMID: 34749916 Review.
-
Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.J Pediatr Hematol Oncol. 2014 Jul;36(5):353-61. doi: 10.1097/MPH.0000000000000131. J Pediatr Hematol Oncol. 2014. PMID: 24608079 Free PMC article. Clinical Trial.
Cited by
-
COVID-19 infection in children with blood cancer: A systematic review.Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5. Ann Hematol. 2025. PMID: 39496811 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous